Back to search
Refractory IPA
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Refractory IPA trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Refractory IPA trials you may qualify forTo assess the safety and efficacy of nebulized PC945 in combination with systemic antifungal therapy for the treatment of refractory IPA
This is a multicenter, open label, non-comparator, single arm study to evaluate the efficacy and safety of ibrexafungerp (SCY-078) in patients ≥ 18 years of age…
The purpose of this study is to determine if Omega-3 fatty acids reduce seizures and modify cardiac risk factors in people with epilepsy.